These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 23460659)
1. Association of a reduction in low-density lipoprotein cholesterol with incident cardiovascular and cerebrovascular events among people with type 2 diabetes mellitus. Li L; Ambegaonkar BM; Reckless JP; Jick S Eur J Prev Cardiol; 2014 Jul; 21(7):855-65. PubMed ID: 23460659 [TBL] [Abstract][Full Text] [Related]
2. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus. Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C; Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835 [TBL] [Abstract][Full Text] [Related]
3. Presence of elevated non-HDL among patients with T2DM with CV events despite of optimal LDL-C - A report from South India. Kumpatla S; Soni A; Narasingan SN; Viswanathan V Indian Heart J; 2016; 68(3):378-9. PubMed ID: 27316499 [TBL] [Abstract][Full Text] [Related]
4. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels. Querton L; Buysschaert M; Hermans MP J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779 [TBL] [Abstract][Full Text] [Related]
5. Risk of major adverse cardiovascular events associated with elevated low-density lipoprotein cholesterol in a population with atherosclerotic cardiovascular disease with and without type 2 diabetes: a UK database analysis using the Clinical Practice Research Datalink. Morgan CL; Durand A; McCormack T; Hughes E; Berni TR; Lahoz R BMJ Open; 2023 Nov; 13(11):e064541. PubMed ID: 38030254 [TBL] [Abstract][Full Text] [Related]
6. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. Ridker PM; Rifai N; Rose L; Buring JE; Cook NR N Engl J Med; 2002 Nov; 347(20):1557-65. PubMed ID: 12432042 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. Suk Danik J; Rifai N; Buring JE; Ridker PM JAMA; 2006 Sep; 296(11):1363-70. PubMed ID: 16985228 [TBL] [Abstract][Full Text] [Related]
8. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model. Shinozaki T; Matsuyama Y; Iimuro S; Umegaki H; Sakurai T; Araki A; Ohashi Y; Ito H; Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():88-102. PubMed ID: 22435944 [TBL] [Abstract][Full Text] [Related]
9. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular benefit of magnitude of low-density lipoprotein cholesterol reduction: a comparison of subgroups by age. Rahilly-Tierney CR; Lawler EV; Scranton RE; Gaziano JM Circulation; 2009 Oct; 120(15):1491-7. PubMed ID: 19786636 [TBL] [Abstract][Full Text] [Related]
11. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Callahan A; Amarenco P; Goldstein LB; Sillesen H; Messig M; Samsa GP; Altafullah I; Ledbetter LY; MacLeod MJ; Scott R; Hennerici M; Zivin JA; Welch KM; Arch Neurol; 2011 Oct; 68(10):1245-51. PubMed ID: 21670382 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States. Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl. Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796 [TBL] [Abstract][Full Text] [Related]
14. Characterization and cholesterol management in patients with cardiovascular events and/or type 2 diabetes in the Netherlands. Heintjes E; Kuiper J; Lucius B; Penning-van Beest F; Kutikova L; Liem A; Herings R Curr Med Res Opin; 2017 Jan; 33(1):91-100. PubMed ID: 27646783 [TBL] [Abstract][Full Text] [Related]
15. Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9 years follow-up in Tehran Lipid and Glucose Study. Tohidi M; Mohebi R; Cheraghi L; Hajsheikholeslami F; Aref S; Nouri S; Azizi F; Hadaegh F Clin Biochem; 2013 Jun; 46(9):716-21. PubMed ID: 23531403 [TBL] [Abstract][Full Text] [Related]
16. LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes. Hero C; Svensson AM; Gidlund P; Gudbjörnsdottir S; Eliasson B; Eeg-Olofsson K Diabet Med; 2016 Mar; 33(3):316-23. PubMed ID: 26498834 [TBL] [Abstract][Full Text] [Related]
17. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals. Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862 [TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. Okamura T; Kokubo Y; Watanabe M; Higashiyama A; Miyamoto Y; Yoshimasa Y; Okayama A Atherosclerosis; 2009 Apr; 203(2):587-92. PubMed ID: 18783774 [TBL] [Abstract][Full Text] [Related]
19. Impact of diabetes, high triglycerides and low HDL cholesterol on risk for ischemic cardiovascular disease varies by LDL cholesterol level: a 15-year follow-up of the Chinese Multi-provincial Cohort Study. Liu J; Wang W; Wang M; Sun J; Liu J; Li Y; Qi Y; Wu Z; Zhao D Diabetes Res Clin Pract; 2012 May; 96(2):217-24. PubMed ID: 22244364 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese. Gu X; Yang X; Li Y; Cao J; Li J; Liu X; Chen J; Shen C; Yu L; Huang J; Gu D Am J Cardiol; 2015 Oct; 116(7):1063-70. PubMed ID: 26250998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]